LEXICON PHARMACEUTICALS, INC. - COMMON STOCK (LXRX)

Historical Holders from Q2 2015 to Q3 2025

Symbol
LXRX on Nasdaq
CUSIP
528872302
Type / Class
Equity / COMMON STOCK
Shares outstanding
363M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
255M
Holdings value
$344M
% of all portfolios
0%
Grand Portfolio weight change
0%
Number of holders
120
Number of buys
44
Number of sells
-58
Average Value change %
0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of LEXICON PHARMACEUTICALS, INC. - COMMON STOCK (LXRX)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
FMR LLC 10.5% +9% $24M $2.26M 38.1M +10.4% FMR LLC Jun 30, 2025

Institutional Holders of LEXICON PHARMACEUTICALS, INC. - COMMON STOCK (LXRX)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 255M $344M -$1.11M $1.35 120
2025 Q2 256M $243M -$6.85M $0.95 122
2025 Q1 266M $122M -$18.1M $0.46 123
2024 Q4 298M $220M -$8.08M $0.74 123
2024 Q3 289M $453M -$48.6M $1.57 134
2024 Q2 278M $468M +$176M $1.68 122
2024 Q1 172M $412M -$23.4M $2.40 115
2023 Q4 37.4K $57.2K $1.53 1
2023 Q3 189M $206M -$5.68M $1.09 109
2023 Q2 191M $438M +$105M $2.29 120
2023 Q1 146M $354M -$3M $2.43 102
2022 Q4 147M $280M -$3.98M $1.91 98
2022 Q3 149M $357M +$72.6M $2.40 97
2022 Q2 119M $221M -$2.4M $1.86 81
2022 Q1 120M $251M -$5.49M $2.09 101
2021 Q4 121M $478M -$1.63M $3.94 104
2021 Q3 121M $583M +$17.7M $4.81 95
2021 Q2 118M $540M +$1.97M $4.59 103
2021 Q1 121M $712M +$170K $5.87 104
2020 Q4 50.8M $174M +$28.6M $3.42 98
2020 Q3 100M $144M -$4.78M $1.44 80
2020 Q2 107M $213M +$4.6M $1.99 95
2020 Q1 105M $204M -$17.1M $1.95 101
2019 Q4 107M $443M +$21M $4.15 106
2019 Q3 102M $308M -$29.7M $3.01 93
2019 Q2 105M $661M +$7.24M $6.29 103
2019 Q1 104M $579M -$5.05M $5.56 109
2018 Q4 105M $696M -$17.9M $6.64 113
2018 Q3 103M $1.1B -$14.5M $10.67 109
2018 Q2 104M $1.25B +$2.2M $12.00 109
2018 Q1 110M $939M -$14.3M $8.57 118
2017 Q4 111M $1.1B -$43.7M $9.88 122
2017 Q3 110M $1.36B -$5.73M $12.29 127
2017 Q2 110M $1.82B +$18.3M $16.45 124
2017 Q1 109M $1.57B +$113M $14.34 127
2016 Q4 106M $1.46B -$2.37M $13.83 135
2016 Q3 106M $1.92B -$1.51M $18.07 135
2016 Q2 111M $1.59B +$1.16M $14.35 131
2016 Q1 111M $1.32B +$12.4M $11.95 123
2015 Q4 110M $1.46B +$55M $13.31 115
2015 Q3 106M $1.14B +$97.7M $10.74 98
2015 Q2 96.4M $776M +$741M $8.05 85